Clinical Trial Update: Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating local therapy with a PD-1 inhibitor for esophageal squamous cell carcinoma with oligometastatic disease is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• PD-1 inhibitor

Snippet

Sponsor: Fudan University | Conditions: Esophageal Squamous Cell Carcinoma, Oligometastatic Disease | Phase 3 | Status: RECRUITING